T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Under Armour
UAA
$2.3B
| $45.2M | 0.01% |
933,476
-4,594,180
| -83% | -$218M |
|
802
Marathon Petroleum
MPC
$100B
| $44.9M | 0.01% |
969,958
-2,002,178
| -67% | -$103M |
|
803
Coca-Cola Consolidated
COKE
$12.7B
| $44.7M | 0.01% |
2,310,390
-970,510
| -30% | -$15.8M |
|
804
AGCO
AGCO
$6.96B
| $44.6M | 0.01% |
955,570
+7,760
| +0.8% | +$397K |
|
|
ANDV
805
DELISTED
Andeavor
ANDV
| $44.5M | 0.01% |
457,653
+106,130
| +30% | +$10.3M |
|
|
KTWO
806
DELISTED
K2M Group Holdings, Inc
KTWO
| $44.1M | 0.01% |
2,373,560
+11,550
| +0.5% | +$253K |
|
|
IRBT
807
DELISTED
iRobot
IRBT
| $44M | 0.01% |
1,509,000
+5,200
| +0.3% | +$158K |
|
|
CERN
808
DELISTED
Cerner Corp
CERN
| $44M | 0.01% |
733,047
+15,030
| +2% | +$982K |
|
809
Simpson Manufacturing
SSD
$8B
| $43.9M | 0.01% |
1,310,620
+5,470
| +0.4% | +$191K |
|
810
Culp Inc
CULP
$43.2M
| $43.8M | 0.01% |
1,365,647
-163,200
| -11% | -$5.15M |
|
811
Abercrombie & Fitch
ANF
$4.84B
| $43.7M | 0.01% |
2,063,850
-1,275,150
| -38% | -$25.9M |
|
812
TherapeuticsMD
TXMD
$24.1M
| $43.6M | 0.01% |
148,715
+57,186
| +62% | +$20.3M |
|
813
Silicon Laboratories
SLAB
$7.28B
| $43.4M | 0.01% |
1,044,290
-21,650
| -2% | -$988K |
|
|
VIVO
814
DELISTED
Meridian Bioscience Inc
VIVO
| $43.4M | 0.01% |
2,536,085
-30,460
| -1% | -$557K |
|
815
Edwards Lifesciences
EW
$53.4B
| $43.4M | 0.01% |
1,829,550
-3,600
| -0.2% | -$86.9K |
|
816
Tyler Technologies
TYL
$13.5B
| $43.3M | 0.01% |
290,000
+12,200
| +4% | +$1.71M |
|
|
TIF
817
DELISTED
Tiffany & Co.
TIF
| $43.2M | 0.01% |
559,292
-47,388
| -8% | -$4.15M |
|
|
ARMH
818
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $43.2M | 0.01% |
998,450
+28,100
| +3% | +$1.25M |
|
819
Angi Inc
ANGI
$196M
| $43.2M | 0.01% |
856,480
+40,136
| +5% | +$2.05M |
|
820
Tootsie Roll Industries
TR
$3.02B
| $43.1M | 0.01% |
1,905,824
+195,204
| +11% | +$4.49M |
|
821
Ethan Allen Interiors
ETD
$583M
| $42.9M | 0.01% |
1,623,770
-156,660
| -9% | -$4.59M |
|
822
Forestar Group
FOR
$1.51B
| $42.8M | 0.01% |
3,254,860
+438,860
| +16% | +$5.65M |
|
|
SPLK
823
DELISTED
Splunk Inc
SPLK
| $42.8M | 0.01% |
773,015
+368,656
| +91% | +$24.1M |
|
824
Welltower
WELL
$169B
| $42.3M | 0.01% |
624,830
+6,720
| +1% | +$449K |
|
|
CDR
825
DELISTED
Cedar Realty Trust, Inc
CDR
| $42.3M | 0.01% |
1,032,144
+279,317
| +37% | +$12M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.